Russian Vaccine Maker to Sue Brazil After Accusation of Poor Quality Control

Russian Vaccine Maker to Sue Brazil After Accusation of Poor Quality Control


The Gamaleya Institute, the Russian company responsible for the Chinese coronavirus vaccine candidate Sputnik V, announced on Thursday it would sue Brazil’s health regulators for defamation after they refused to grant authorization for distribution of the product.

The Brazilian National Health Surveillance Agency (Anvisa) issued an extensive statement on Thursday announcing it had rejected requests from several Brazilian states and the federal government to grant emergency use authorization to Sputnik V, the first vaccine candidate developed against the novel Chinese coronavirus to receive approval since the pathogen first began infecting humans. Anvisa stated in its explanation that it had repeatedly requested that the Moscow-linked Gamaleya Institute provide more detailed data on the manufacturing of the vaccine candidate and had not received it.

The statement also claimed that Brazilian officials visited manufacturing plants in Russia and found no uniform standards for quality control and that, in some samples tested in

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!
Thanks for sharing!
Send this to a friend